Navigation Links
BioLife Solutions Named One of Washington's Best Companies
Date:6/24/2013

BOTHELL, Wash., June 24, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced that it has been named by Seattle Business Magazine as one of the best places to work in Washington state.

(Photo: http://photos.prnewswire.com/prnh/20130624/LA36677)

(Logo: http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO)

Now in its 23rd year, this competition salutes Washington companies setting the standard for leadership, strong benefits, ideal work environment, innovative training, happiest employees and more.  Winners were recognized at an awards dinner held on June 20th at the Westin Hotel in Seattle.

Mike Rice, Chief Executive Officer, commented, "Our entire team is very honored and proud to receive this recognition.  It is gratifying to see our people and special corporate culture acknowledged within the Washington state business community.  We have built a very solid, high performance team that is the single greatest contributor to the success BioLife has achieved since the Company relocated to Bothell in early 2007.  I'm honored to have the opportunity to lead such a dedicated and capable team."

In 2012, BioLife doubled revenue over 2011, doubled the size of its workforce to nearly 30 team members, and firmly established its products as best in class, clinical grade biopreservation storage and freeze media for cells, tissues, and organs.  Shares of the Company have recently traded at nearly 10 times above a previous low price set in January 2011.

Rice continued, "BioLife is a very special place to work.  A requirement for teamwork and open and honest communication is a hallmark of our merit-based culture and a foundational principal of my management philosophy."

For the complete list of winning companies, please visit: http://seattlebusinessmag.com.

About BioLife SolutionsBioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues.  The Company's proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce biopreservation-induced cell damage and death.  BioLife's enabling technology provides academic and clinical researchers, and commercial companies significant improvements in post-thaw cell, tissue, and organ viability and function.  For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact.  Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission.  BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.  Media Relations:

Investor Relations:Len Hall

Matt ClawsonAllen & Caron Inc

Allen & Caron Inc(949) 474-4300

(949) 474-4300len@allencaron.com

matt@allencaron.com
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013
2. BioLife Solutions Announces License Agreement
3. BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue
4. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
5. BioLife Solutions Announces 2012 Second Quarter Results: Eighth Straight Quarter of Record Revenue
6. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
7. Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION
8. BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
9. BioLife Solutions 2011 Revenue Up 33%
10. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
11. Accel-KKR Makes Growth Equity Investment in Zinc Ahead, Leading Provider of Marketing Compliance Solutions for the Life Sciences Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2017)...  Trianni, Inc. („TRIANNI") gab heute bekannt, man ... über die Verwendung der The Trianni Mouse unterschrieben, ... Entdeckung monoklonaler Antikörper. Die Trianni Plattform ... das Janssen den Zugang zu einer ... für die schelle Isolierung vollständig menschlicher Therapeutika optimiert ...
(Date:2/15/2017)... 2017  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), ... fourth quarter and full year ended December 31, ... for Vanda as we continued to demonstrate strong ... exclusivity for Fanapt," said Mihael H. Polymeropoulos, M.D., ... pipeline with important 2017 milestones underscores Vanda,s commitment ...
(Date:2/15/2017)... Feb. 15, 2017 Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, will ... presentation) at 8:00 AM EST on Thursday, February 16, ... clinical program, the recently announced closing of a $10.5 ... To participate in the live call and ...
(Date:2/15/2017)... ... February 15, 2017 , ... Diameter Health ... Diameter Health technology in the hands of Lantana analysts. The high-performance platform of ... and public health entities – all those mining value from clinical data – ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
Breaking Biology News(10 mins):